Benralizumab, sold under the brand name Fasenra, is a monoclonal antibody directed against the alpha chain of the interleukin-5 receptor (CD125). It was...
5 KB (286 words) - 05:02, 7 September 2024
mepolizumab or reslizumab against IL-5, prevents eosinophilopoiesis, or benralizumab against IL-5 receptor, which eliminates eosinophils through ADCC antagonists...
29 KB (3,166 words) - 00:19, 9 September 2024
symptoms. Some examples of these drugs include mepolizumab, reslizumab, and benralizumab. Although eosinopenia has long been recognized as a laboratory marker...
15 KB (1,693 words) - 15:08, 25 April 2024
On 18 September 2024, AstraZeneca announced FDA approval for Fasenra (benralizumab), a biologic drug therapy indicated for use in adult patients with EGPA...
30 KB (2,813 words) - 01:10, 1 October 2024
(IL-5) or its receptor (IL-5R), including mepolizumab, reslizumab or benralizumab, in addition to standard care in severe asthma is effective in reducing...
167 KB (18,030 words) - 09:27, 19 September 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
42 KB (3,486 words) - 00:32, 30 September 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
56 KB (5,566 words) - 04:53, 25 September 2024
drug is a human monoclonal antibody acting against tumors. The name of benralizumab, a drug designed for the treatment of asthma, has the components benra-li-zu-mab...
38 KB (3,088 words) - 05:02, 8 August 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
31 KB (2,632 words) - 23:43, 9 October 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
42 KB (3,798 words) - 03:37, 17 September 2024
asthma symptomatic control include omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab and tezepelumab. Omalizumab binds to free human immunoglobulin...
26 KB (2,749 words) - 01:59, 28 July 2024
Pascolizumab IL-5 Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists:...
22 KB (1,812 words) - 09:08, 9 October 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
16 KB (1,284 words) - 04:32, 23 September 2024
IL-4-specific blockers: Altrakincept Pascolizumab IL-5-specific blockers: Benralizumab Mepolizumab Reslizumab IL-13-specific blockers: Lebrikizumab Tralokinumab...
5 KB (560 words) - 00:25, 17 July 2024
Pascolizumab IL-5 Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists:...
12 KB (1,289 words) - 19:20, 4 December 2023
Pascolizumab IL-5 Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists:...
37 KB (2,868 words) - 23:35, 14 October 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
10 KB (836 words) - 03:56, 30 September 2024
(anti-PD-L1) tremelimumab (anti-CTLA-4) moxetumomab pasudotox (anti-CD22) benralizumab (anti-IL-5R) tralokinumab (anti-IL-13) anifrolumab (anti-IFN-aR) nirsevimab...
9 KB (800 words) - 00:48, 28 October 2023
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
53 KB (4,975 words) - 03:43, 30 September 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
44 KB (3,805 words) - 00:43, 23 July 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
10 KB (778 words) - 01:56, 27 September 2024
Pascolizumab IL-5 Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists:...
49 KB (6,005 words) - 13:33, 14 October 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
31 KB (2,779 words) - 19:04, 15 October 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
6 KB (352 words) - 17:16, 16 May 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
33 KB (3,283 words) - 03:54, 15 September 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
91 KB (9,320 words) - 03:57, 2 October 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
14 KB (718 words) - 14:56, 19 July 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
86 KB (7,963 words) - 18:33, 12 September 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
24 KB (2,132 words) - 11:10, 7 September 2024
Pascolizumab IL-5 Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists:...
17 KB (1,245 words) - 14:04, 2 September 2024